Clinical Trial Update: Autologous Hematopoietic Stem Cell Boost Study After CAR-T Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating autologous hematopoietic stem cell boost after CAR-T therapy in patients with diffuse large B-cell lymphoma, currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Autologous hematopoietic stem cell boost after CAR-T therapy

Snippet

Sponsor: Ruijin Hospital | Conditions: Diffuse Large B Cell Lymphoma | Phase 2 | Status: RECRUITING